Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

By: Institute of Medicine (author), Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease (author), Food and Nutrition Board (author), Board on Health Sciences Policy (author), John R. Ball (editor), Christine M. Micheel (editor)Paperback

Up to 2 WeeksUsually despatched within 2 weeks

Description

Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.

Contents

1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Review: Evaluating and Regulating Biomarker Use; 5 3 The Biomarker Evaluation Process; 6 4 Case Studies; 7 5 Strengthening Evidence-Based Regulation; 8 Acronyms; 9 Glossary; 10 Appendix A: Table of Papers About Biomarker Qualification; 11 Appendix B: Recommendations from Related IOM Reports; 12 Appendix C: Committee Member and Consultant Biographies; 13 Appendix D: Staff Biographies; 14 Appendix E: Workshop Agenda; 15 Appendix F: Speaker Biographies

Product Details

  • ISBN13: 9780309151290
  • Format: Paperback
  • Number Of Pages: 334
  • ID: 9780309151290
  • ISBN10: 0309151295

Delivery Information

  • Saver Delivery: Yes
  • 1st Class Delivery: Yes
  • Courier Delivery: Yes
  • Store Delivery: Yes

Prices are for internet purchases only. Prices and availability in WHSmith Stores may vary significantly

Close